Patents by Inventor Albert Scheller

Albert Scheller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120027678
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: February 18, 2011
    Publication date: February 2, 2012
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030086915
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 25, 2002
    Publication date: May 8, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030064057
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 28, 2002
    Publication date: April 3, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030064022
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 28, 2002
    Publication date: April 3, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030064059
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 25, 2002
    Publication date: April 3, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030059408
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 25, 2002
    Publication date: March 27, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030059415
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 28, 2002
    Publication date: March 27, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030053992
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 25, 2002
    Publication date: March 20, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030053996
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 25, 2002
    Publication date: March 20, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030053997
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 28, 2002
    Publication date: March 20, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030049238
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 28, 2002
    Publication date: March 13, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030049206
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 28, 2002
    Publication date: March 13, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030049233
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 25, 2002
    Publication date: March 13, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030039642
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 25, 2002
    Publication date: February 27, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030017587
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: July 18, 2001
    Publication date: January 23, 2003
    Inventors: William C. Rader, Albert Scheller
  • Patent number: 6468312
    Abstract: The invention relates to a bionic organ replacement which has a structure consisting of three groups of textile hollow microfibers. The hollow microfibers of each group run into in a liquid conductor which is central respectively. The hollow microfibers of the first group (1) are made from a proton-conducting material and have perforations (2) for draining bile into the area inside the fibers (1). One of the surfaces in essentially every hollow microfiber (1) of the first group (1) is hydrophilic and lipophilic whilst the other surface is hydrophobic and lipophobic. Cell cultures can be grown on the outer surfaces of all of the hollow microfibers.
    Type: Grant
    Filed: April 9, 2001
    Date of Patent: October 22, 2002
    Inventors: Klaus Rennebeck, Albert Scheller
  • Patent number: 4968302
    Abstract: Automatic injection device, as well as ampoule or cartridge for the same. In order to obtain a high speed discharge of an ampoule-hypodermic needle, as well as to ensure an operationally reliable, low weight, robust small apparatus or ampoule at long storability, sterility and re-usability of components for a plurality of injection substances, the needle body (30) of the cannulahypodermic needle (3) is constructed over part of its extension as a needle bearing (31) guided in sliding fit on the inner wall (21) of the cartridge (2). Particularly with a view to administering separate injection substances, it is provided for a cartridge or ampoule with needle and lifting element, that within the ampoule there is arranged a receptacle forming a gas volume, which receptacle can be destroyed easily by initiating the lifting movement and which is resistant to the injection fluid surrounding it.
    Type: Grant
    Filed: April 26, 1988
    Date of Patent: November 6, 1990
    Assignee: Eberhardt Schluter
    Inventors: Eberhardt Schluter, Albert Scheller, Rolf Sprenger